0000803578 1 2026-06-23 2026-06-23 0000803578 2 2026-06-23 2026-06-23 0000803578 3 2026-06-23 2026-06-23 0000803578 4 2026-06-23 2026-06-23 0000803578 1 2026-06-23 2026-06-23 0000803578 2 2026-06-23 2026-06-23 0000803578 2026-06-23 2026-06-23 iso4217:USD pure shares S-3/A EX-FILING FEES 0000803578 333-296046 true false N/A S-3 Firefly Neuroscience, Inc. false Equity Common Stock, par value $0.0001 per share true 1213175 1.49 1807630.75 0.0001381 249.63 false Equity Common stock, par value $0.0001 per share, issuable upon exercise of pre-funded warrants true 5620158 1.49 8374035.42 0.0001381 1156.45 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 6833333 1.49 10181666.17 0.0001381 1406.09 false Equity Common stock, par value $0.001 per share, issuable upon exercise of common stock purchase warrants true 6833333 1.49 10181666.17 0.0001381 1406.09 30544998.51 4218.26 0.00 4218.26 0.00 Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on June 16, 2026.<br/><br/>Represents up to 1,213,175 shares of Common Stock issued pursuant to the to that certain Securities Purchase Agreement, dated March 8, 2026 (the “March 2026 Securities Purchase Agreement”), by and between the and the Registrant and other parties signatory.<br/><br/>Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on June 16, 2026. (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).<br/><br/>The Registrant has subsequently reduced the total registered amount of Common Stock being offered to 20,499,999 shares. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on June 16, 2026.<br/><br/>Represents up to 5,620,158 shares of Common Stock issuable upon exercise of certain pre funded warrants with an initial exercise price of $0.0001 per share pursuant to the March 2026 Securities Purchase Agreement.<br/><br/>Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on June 16, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).<br/><br/>The Registrant has subsequently reduced the total registered amount of Common Stock being offered to 20,499,999 shares. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on June 16, 2026.<br/><br/>Represents up to 6,833,333 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $1.80 per share pursuant to the March 2026 Securities Purchase Agreement;.<br/><br/>Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on June 16, 2026 (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).<br/><br/>The Registrant has subsequently reduced the total registered amount of Common Stock being offered to 20,499,999 shares. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the common stock, par value $0.0001 per share (“Common Stock”) of Firefly Neuroscience, Inc. (the “Registrant”) reported by The Nasdaq Stock Market LLC on June 16, 2026.<br/><br/>Represents up to 6,833,333 shares of Common Stock issuable upon exercise of common stock purchase warrants with an initial exercise price of $2.50 per share pursuant to the March 2026 Securities Purchase Agreement.<br/><br/>Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of common stock on The Nasdaq Global Select Market on June 16, 2026. (such date being within five business days of the date that this registration statement was first filed with the Securities and Exchange Commission, in accordance with Rule 457(c) under the Securities Act).<br/><br/>The Registrant has subsequently reduced the total registered amount of Common Stock being offered to 20,499,999 shares. true S-3 333-296046 2026-05-20 4218.26 Equity Common Stock, par value $0.0001 per share true Firefly Neuroscience, Inc. S-3 333-296046 2026-05-20 5282.33 The Registrant’s Registration Statement on Form S-3 (Registration No. 333-296046) was initially filed on May 20, 2026. At the time of filing, the Registrant paid a fee of $5,282.33for a transaction with the Total Offering Amount of $38,250,000.00. As described in Table 1, the revised Total Offering Amount is $30,544,998.51. Therefore, the Registrant has overpaid the filing fees for the current transaction by $1,064.07 and claims a fee offset of $4,218.26.